Feature | October 04, 2013

Latest IMV Market Report Shows Increased Cath Lab Purchase Activity Over Next Three Years

Cath lab IMV market report

October 4, 2013 — Purchasing activity for cardiac catheterization labs in the United States appears to be growing as more healthcare facilities look to replace aging equipment, according to a new report by IMV Medical Information Division. The census-based report finds that both patient volume and installed base are rising as the market recovers from a recent slowdown.

According to the report, patient volume has increased at a rate of 0.5 percent per year, and the number of identified fixed cath lab systems has increased at an average annual growth rate of 3.3 percent, from 4,225 units as of IMV’s 2008 census to 4,980 units in 2012. Going forward, an estimated 44 percent of surveyed cath lab sites are considering the purchase of cath lab units over the next three years to replace units or add rooms. This is likely due to several factors, including:

· An installed base of older units. The average replacement cycle is 11.1 years for sites that are planning to replace their units, which is up from 10 years in 2008. While cath lab facilities are holding on to their units longer, the peak years of cath lab installations occurred about a decade ago, so sites are replacing a larger number of aging units.

· Continued innovation and interest in using the cath lab rooms for minimally invasive procedures, including noncardiac procedures such as carotid, iliac, femoral, runoff, renal and extremity studies. Since 2000, the proportion of cath lab rooms being used for noncardiac cases has increased from 47 percent to 67 percent of rooms. In addition to diagnostic cardiologists and interventional radiologists, cardiothoracic surgeons and endovascular/vascular surgeons are performing procedures in cath lab settings.

· More than one-third of purchase plans are for adding fixed C-arms for use with cardiac and noncardiac procedures. In addition to adding units to the traditional cath lab or cardiology suites, at least 7 percent of sites are planning to locate their additional units in surgery/operating room (OR) departments.

An estimated 3.82 million patient cases were performed at 2,100 cardiac cath lab sites in 2012, including both cardiac and noncardiac patient cases. During the past decade, the total volume of patient cases peaked in 2006 at 4.21 million and declined to a low of 3.75 million in 2008. Since 2009, total patient volume has been relatively stable, increasing at an average annual growth rate of 0.5 percent.

“This slowdown in patient cases handled by cath labs is due to the convergence of several factors,” observed Lorna Young, senior director, Market Research at IMV. “With the advent of CT coronary angiography procedures (CTA), the volume of diagnostic cath procedures appears to have declined. In addition, the increased use of preauthorization policies by third party insurers may be at play.”

For more information: www.imvinfo.com

Related Content

bioresorbable stents, bioabsorbable stents, visualizing the Absorb BVS, dissolving stent, disappearing stent on IVUS and OCT

A comparison of how the Abbott Absorb BVS appears with intravascular ultrasound (IVUS) on the left, and optical coherence tomography (OCT) of the right. The stent is difficult to visualize and sizing is critical, so both modalities can help in bioresorbable stent measurements and to confirm stent apposition. Left image from the Volcano IVUS system and the right image from St. Jude Medical's OCT system


Feature | Stents Bioresorbable| October 20, 2016 | Dave Fornell
There has been a lot of interest in the interventional community regarding the Abbott Absorb Bioresorbable Vascular S
Avinger, Pantheris atherectomy catheter, OCT, Lumivascular technology, expanded FDA indication, diagnostic imaging device
News | Atherectomy Devices| October 20, 2016
Avinger Inc. recently announced that the company has received expanded indications from the U.S. Food and Drug...
recall, alligator retrieval device, X-Celerator hydrophilic guidewire, UltraFlow flow directed micro catheters, Marathon flow directed micro catheters
News | Cath Lab| October 18, 2016
Medtronic plc announced last week that it has notified customers of a voluntary recall of certain lots of its Pipeline...
Inventory management, Cardinal, RFID inventory tracking, cath lab inventory
Sponsored Content | Whitepapers | Inventory Management| October 18, 2016
As healthcare moves into the era of bundled payments, providers need to be especially focused on ensuring delivery of
angioseal, angio-seal, terumo, St. Jude, vascular closure devices
News | Vascular Closure Devices| October 18, 2016
October 18, 2016 — Abbott and St. Jude Medical Inc.
3-D bioprinting, 3-D printing, printed organs, 3D bioprinting

3-D printed vessel made from living cells implanted in an animal to test feasibility of using such structures clinically. Blood vessels are a stepping stone to the creation of more complex 3-D printed organs made from biomaterials. Image from the South Carolina Project for Organ Biofabrication.


Feature | 3-D Printing| October 13, 2016 | Dave Fornell
The U.S. Food and Drug Administration (FDA) changed its rules concerning custom medical devices Oct.
Shockwave lithoplasty system, VIVA 16, Vascular Interventioanl Advances, VIA Physicians, late-breaking endovascular clinical trial results
News | Cath Lab| October 12, 2016
VIVA (Vascular Interventional Advances) Physicians announced a number of highly anticipated late-breaking clinical...
Terumo Finecross, guidewires, guide wires, guidewires 101, basics of guidewire technology

An illustration of Terumo's Finecross guidewire crossing a tight lesion. 

Feature | Guidewires| October 12, 2016 | Dave Fornell
While guidewires are a key tool used by
Medtronic, FDA clearance, TrailBlazer peripheral angled support catheter, PAD, peripheral artery disease
Technology | Peripheral Arterial Disease (PAD)| October 12, 2016
Medtronic plc announced recently that the U.S. Food and Drug Administration (FDA) has cleared the TrailBlazer angled...
Cardioband, first tricuspid valve repair, University Hospital Zurich, Francesco Maisano
News | Heart Valve Technology| October 10, 2016
Francesco Maisano, clinic director at the University Hospital Zurich, recently led a team of cardiac surgeons and...
Overlay Init